Subscribe
shutterstock_596091488_1000_words
1000 words / Shutterstock.com
25 September 2019EuropeRory O'Neill

UK Labour promises public generics company, compulsory drug licensing

Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service (NHS).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Labour peer says vaccine IP should be waived during a pandemic
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.
Generics
Russian government approves compulsory drug licensing bill
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Generics
China awards generics contracts to lowest bidders
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025

More on this story

Big Pharma
Labour peer says vaccine IP should be waived during a pandemic
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.
Generics
Russian government approves compulsory drug licensing bill
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Generics
China awards generics contracts to lowest bidders
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

More on this story

Big Pharma
Labour peer says vaccine IP should be waived during a pandemic
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.
Generics
Russian government approves compulsory drug licensing bill
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Generics
China awards generics contracts to lowest bidders
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

More features

Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
Boies Schiller Flexner adds three-strong litigation team